Novartis in Australia and New Zealand continues to closely monitor and respond to the coronavirus (COVID-19) situation. Our priority is to ensure the health and safety of our people, patients, and healthcare professionals.
The Novartis community would like to express our thoughts and condolences to all of those affected by the bushfires in Australia.
